International Journal of Infection

Published by: Kowsar

Reduction of Invasive Fungal Infections Among Cancer Patients With Chemotherapy-Induced Neutropenia After Protective Environment Implementation May Save Costs in a Developing Country: A Quasi-Experimental Study

Paula Stoll 1 , * , Caroline Mioto Menegat Cola 2 , Bruno Ismail Splitt 2 and Leila Beltrami Moreira 3 , 4
Authors Information
1 Post-Graduate Program in Medical Sciences, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
2 College of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
3 Department of Pharmacology, ICBS, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
4 Pharmacy and Therapeutics Committee on Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Article information
  • International Journal of Infection: January 01, 2016, 3 (1); e32937
  • Published Online: November 30, 2015
  • Article Type: Research Article
  • Received: September 4, 2015
  • Revised: October 14, 2015
  • Accepted: October 17, 2015
  • DOI: 10.17795/iji-32937

To Cite: Stoll P, Cola C M M, Splitt B I, Moreira L B. Reduction of Invasive Fungal Infections Among Cancer Patients With Chemotherapy-Induced Neutropenia After Protective Environment Implementation May Save Costs in a Developing Country: A Quasi-Experimental Study, Int J Infect. 2016 ; 3(1):e32937. doi: 10.17795/iji-32937.

Copyright © 2015, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Martino R, Subira M. Invasive fungal infections in hematology: new trends. Ann Hematol. 2002; 81(5): 233-43[DOI][PubMed]
  • 2. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002; 34(7): 909-17[DOI][PubMed]
  • 3. Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006; 91(8): 1068-75[PubMed]
  • 4. Martino R, Subira M, Rovira M, Solano C, Vazquez L, Sanz GF, et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol. 2002; 116(2): 475-82[PubMed]
  • 5. Jantunen E, Salonen J, Juvonen E, Koivunen E, Siitonen T, Lehtinen T, et al. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Eur J Haematol. 2004; 73(3): 174-8[DOI][PubMed]
  • 6. Velasco E, Bigni R. A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia. Eur J Clin Microbiol Infect Dis. 2008; 27(11): 1071-8[DOI][PubMed]
  • 7. Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kahkola P, et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant. 1997; 19(8): 801-8[DOI][PubMed]
  • 8. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, et al. Guidelines for preventing healthcare-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004; 53: 1-36[PubMed]
  • 9. Fenelon LE. Protective isolation: who needs it? J Hosp Infect. 1995; 30 Suppl: 218-22[PubMed]
  • 10. Maertens J, Vrebos M, Boogaerts M. Assessing risk factors for systemic fungal infections. Eur J Cancer Care (Engl). 2001; 10(1): 56-62[PubMed]
  • 11. Centers for Disease Control and Prevention , Infectious Disease Society of America , American Society of Blood , Marrow Transplantation. . Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000; 49: 1-125[PubMed]
  • 12. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory C. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007; 35(10 Suppl 2)-164[DOI][PubMed]
  • 13. Humphreys H. Positive-pressure isolation and the prevention of invasive aspergillosis. What is the evidence? J Hosp Infect. 2004; 56(2): 93-100[DOI][PubMed]
  • 14. Benet T, Nicolle MC, Thiebaut A, Piens MA, Nicolini FE, Thomas X, et al. Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. Clin Infect Dis. 2007; 45(6): 682-6[DOI][PubMed]
  • 15. Araujo R, Carneiro A, Costa-Oliveira S, Pina-Vaz C, Rodrigues AG, Guimaraes JE. Fungal infections after haematology unit renovation: evidence of clinical, environmental and economical impact. Eur J Haematol. 2008; 80(5): 436-43[DOI][PubMed]
  • 16. Schlesinge A, Paul M, Gafter-Gvili A, Rubinovitch B, Leibovici L. Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis. Lancet Infect Dis. 2009; 9(2): 97-107[DOI]
  • 17. Sehulster L, Chinn RY. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003; 52: 1-42[PubMed]
  • 18. Stoll P, Silla LM, Cola CM, Splitt BI, Moreira LB. Effectiveness of a Protective Environment implementation for cancer patients with chemotherapy-induced neutropenia on fever and mortality incidence. Am J Infect Control. 2013; 41(4): 357-9[DOI][PubMed]
  • 19. Zuckermann J, Moreira LB, Stoll P, Moreira LM, Kuchenbecker RS, Polanczyk CA. Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes. Ann Hematol. 2008; 87(2): 139-45[DOI][PubMed]
  • 20. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002; 34(1): 7-14[DOI][PubMed]
  • 21. Einsele H, Bertz H, Beyer J, Kiehl MG, Runde V, Kolb HJ, et al. Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2003; 82 Suppl 2-85[DOI][PubMed]
  • 22. Sherertz RJ, Belani A, Kramer BS, Elfenbein GJ, Weiner RS, Sullivan ML, et al. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med. 1987; 83(4): 709-18[PubMed]
  • 23. Loo VG, Bertrand C, Dixon C, Vitye D, DeSalis B, McLean AP, et al. Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol. 1996; 17(6): 360-4[PubMed]
  • 24. Oren I, Haddad N, Finkelstein R, Rowe JM. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol. 2001; 66(4): 257-62[DOI][PubMed]
  • 25. Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect. 2006; 63(3): 246-54[DOI][PubMed]
  • 26. Alberti C, Bouakline A, Ribaud P, Lacroix C, Rousselot P, Leblanc T, et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J Hosp Infect. 2001; 48(3): 198-206[DOI][PubMed]
  • 27. Hahn T, Cummings KM, Michalek AM, Lipman BJ, Segal BH, McCarthy PL. Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect Control Hosp Epidemiol. 2002; 23(9): 525-31[DOI][PubMed]
  • 28. Raad I, Hanna H, Osting C, Hachem R, Umphrey J, Tarrand J, et al. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol. 2002; 23(1): 41-3[DOI][PubMed]
  • 29. Aquino VR, Goldani LZ, Pasqualotto AC. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia. 2007; 163(4): 191-202[DOI][PubMed]
  • 30. Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient--new views of an old problem. Hematology Am Soc Hematol Educ Program. 2001; : 113-39[PubMed]
  • 31. Nucci M, Anaissie E. Emerging fungi. Infect Dis Clin North Am. 2006; 20(3): 563-79[DOI][PubMed]
  • 32. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000; 13(2): 236-301[PubMed]
  • 33. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006; 25(4): 215-29[DOI][PubMed]
  • 34. Pegues CF, Daar ES, Murthy AR. The epidemiology of invasive pulmonary aspergillosis at a large teaching hospital. Infect Control Hosp Epidemiol. 2001; 22(6): 370-4[DOI][PubMed]
  • 35. Thio CL, Smith D, Merz WG, Streifel AJ, Bova G, Gay L, et al. Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol. 2000; 21(1): 18-23[DOI][PubMed]
  • 36. Reich G, Mapara MY, Reichardt P, Dorken B, Maschmeyer G. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant. 2001; 27(5): 525-9[DOI][PubMed]
  • 37. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis. 2001; 33(12): 1959-67[DOI][PubMed]
  • 38. Pittet D, Mourouga P, Perneger TV. Compliance with handwashing in a teaching hospital. Infection Control Program. Ann Intern Med. 1999; 130(2): 126-30[PubMed]
  • 39. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet. 2000; 356(9238): 1307-12[PubMed]
  • 40. Trick WE, Vernon MO, Welbel SF, Demarais P, Hayden MK, Weinstein RA, et al. Multicenter intervention program to increase adherence to hand hygiene recommendations and glove use and to reduce the incidence of antimicrobial resistance. Infect Control Hosp Epidemiol. 2007; 28(1): 42-9[DOI][PubMed]
  • 41. Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L, et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol. 2007; 25(34): 5471-89[DOI][PubMed]
  • 42. Dasbach EJ, Davies GM, Teutsch SM. Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis. 2000; 31(6): 1524-8[DOI][PubMed]
  • 43. Slavin M, Fastenau J, Sukarom I, Mavros P, Crowley S, Gerth WC. Burden of hospitalization of patients with Candida and Aspergillus infections in Australia. Int J Infect Dis. 2004; 8(2): 111-20[PubMed]
  • 44. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008; 46(12): 1813-21[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments